InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Orica Limited (ASX: ORI) - Announcements

Current share price for ORI : $22.860 0.67 (2.85%)+

ASX company news and announcements for Orica Limited (ORI) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Orica Limited (ORI) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Orica Limited (ORI), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Orica Limited (ORI)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$10,592 Ammonium Nitrate Supply Agreement with Terra 22 Jul 2005 9:06AM $18.012 $22.860 risen by 26.91%
$10,592 Earnings Update 22 Jul 2005 9:02AM $18.012 $22.860 risen by 26.91%
$10,592 Breakthrough with Fully Swapped US Private Placement Note 6 May 2005 9:35AM $15.472 $22.860 risen by 47.75%
$10,592 Acquires Aluminates Chemical Industries 21 Mar 2005 2:00PM $19.306 $22.860 risen by 18.41%
$10,592 New Arch Contract in North America 17 Mar 2005 2:16PM $18.975 $22.860 risen by 20.47%
$10,592 Acquires Keith Harris Flavours & Fragrances 21 Jan 2005 2:30PM $18.830 $22.860 risen by 21.41%
$10,592 Acquisition in Latin American Chemicals Businesses 20 Dec 2004 9:08AM $19.462 $22.860 risen by 17.46%
$10,592 New Rio Tinto Contract in North America 17 Nov 2004 10:33AM $18.946 $22.860 risen by 20.66%
$10,592 Acquires Specialty Food Ingredients Distributor 8 Nov 2004 6:06PM $17.681 $22.860 risen by 29.29%
$10,592 Announcement of Buy-Back 3 Nov 2004 12:15PM $17.224 $22.860 risen by 32.72%
$10,592 Production expansion at Yarwun Ammonium Nitrate Plant 29 Oct 2004 4:37PM $17.010 $22.860 risen by 34.39%
$10,592 Tax Audit - 1998 Sale of Pharmaceuticals 6 Oct 2004 1:17PM $16.883 $22.860 risen by 35.40%
$10,592 Qenos Debt Restructure 1 Sep 2004 2:39PM $16.835 $22.860 risen by 35.79%
$10,592 Qenos Debt Restructure 1 Sep 2004 2:39PM $16.202 $22.860 risen by 41.09%
$10,592 Tax Audit - 1998 Sale of Pharmaceuticals Business to Zeneca 30 Aug 2004 6:24PM $16.202 $22.860 risen by 41.09%
$10,592 Further expands specialty Polymers Business 18 Aug 2004 8:52AM $15.618 $22.860 risen by 46.37%
$10,592 Settlement of Taxation Dispute 9 Aug 2004 10:37AM $15.210 $22.860 risen by 50.30%
$10,592 Settlement of Taxation Dispute 9 Aug 2004 10:37AM $15.278 $22.860 risen by 49.63%
$10,592 Production Expansion at Yarwun Ammonium Nitrate Plant 22 Jul 2004 3:16PM $14.684 $22.860 risen by 55.68%
$10,592 Appendix 3F - Final Share Buy Back Notice 11 May 2004 9:10AM $13.867 $22.860 risen by 64.86%
$10,592 Open Briefing - Orica Ltd MD on Delivering our Promises 4 May 2004 5:08PM $14.110 $22.860 risen by 62.01%
$10,592 Half Yearly Report & Half Yearly Accounts 3 May 2004 8:39AM $13.779 $22.860 risen by 65.90%
$10,592 Open Briefing - Orica Ltd MD on B & J Acquisition 28 Apr 2004 9:47AM $15.161 $22.860 risen by 50.78%
$10,592 Open Briefing - Orica Ltd MD on B & J Acquisition 28 Apr 2004 9:47AM $15.161 $22.860 risen by 50.78%
$10,592 Acquires leading specialty food & fine chemicals distributor 27 Apr 2004 9:38AM $14.869 $22.860 risen by 53.74%

951 - 975 of 990 results

Page 39 of 40

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.